Heska Corporation Company Profile (NASDAQ:HSKA)

About Heska Corporation

Heska Corporation logoHeska Corporation develops, manufactures, markets, sells and supports veterinary products. The Company focuses on the canine and feline companion animal health markets. Its segments include Core Companion Animal Health segment, which includes, primarily for canine and feline use, blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing, and Other Vaccines, Pharmaceuticals and Products segment, which includes private label vaccine and pharmaceutical production, primarily for cattle but also for other animals, including small mammals. It offers blood testing instruments and supplies, digital imaging products, software and services, and single use products and services, such as in-clinic heartworm diagnostic tests, heartworm preventive products, allergy immunotherapy products and allergy testing.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Medical Laboratories & Research
  • Sub-Industry: N/A
  • Exchange: NASDAQ
  • Symbol: HSKA
  • CUSIP:
Key Metrics:
  • Previous Close: $81.38
  • 50 Day Moving Average: $79.83
  • 200 Day Moving Average: $64.19
  • 52-Week Range: $6,898,000.00 - $26.26
  • Trailing P/E Ratio: 65.16
  • Foreward P/E Ratio: 52.84
  • P/E Growth: 2.16
  • Market Cap: $561.36M
  • Outstanding Shares: 6,898,000
  • Beta: 0.83
Profitability:
  • Net Margins: 7.55%
  • Return on Equity: 10.46%
  • Return on Assets: 7.84%
Debt:
  • Current Ratio: 2.76%
  • Quick Ratio: 1.62%
Additional Links:
Companies Related to Heska Corporation:

Analyst Ratings

Consensus Ratings for Heska Corporation (NASDAQ:HSKA) (?)
Ratings Breakdown: 5 Hold Ratings
Consensus Rating:Hold (Score: 2.00)
Consensus Price Target: $80.50 (1.08% downside)

Analysts' Ratings History for Heska Corporation (NASDAQ:HSKA)
Show:
DateFirmActionRatingPrice TargetDetails
2/23/2017B. RileyReiterated RatingNeutral$70.50View Rating Details
2/6/2017Benchmark Co.Boost Price TargetHold$78.00 -> $100.00View Rating Details
1/26/2017CL KingDowngradeBuy -> NeutralView Rating Details
11/28/2016SidotiDowngradeBuy -> Neutral$71.00View Rating Details
8/4/2016GabelliDowngradeBuy -> HoldView Rating Details
(Data available from 2/27/2015 forward)

Earnings

Earnings History for Heska Corporation (NASDAQ:HSKA)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
2/28/2017Q416$0.36$34.56 millionN/AView Earnings Details
11/1/2016Q316$0.25$0.45$31.36 million$33.40 millionViewN/AView Earnings Details
8/3/2016Q216$0.18$0.35$28.47 million$30.00 millionViewN/AView Earnings Details
5/3/2016Q116($0.02)$0.17$23.32 million$27.10 millionViewN/AView Earnings Details
3/3/2016Q415$0.17$0.28$28.31 million$29.80 millionViewN/AView Earnings Details
11/11/2015Q315$0.08$0.20$24.31 million$28.00 millionViewListenView Earnings Details
7/29/2015Q215$0.10$0.17$24.11 million$23.90 millionViewListenView Earnings Details
5/7/2015Q115$0.09$0.09$23.97 million$22.90 millionViewN/AView Earnings Details
3/5/2015Q414$0.15$0.12$24.20 million$24.30 millionViewN/AView Earnings Details
10/30/2014($0.01)$0.08ViewN/AView Earnings Details
7/30/2014Q2($0.03)$0.17ViewN/AView Earnings Details
5/9/2014($0.01)$0.03ViewN/AView Earnings Details
3/27/2014$0.04$0.20ViewN/AView Earnings Details
8/7/2013Q2 2013($0.01)($0.38)$19.85 million$18.30 millionViewN/AView Earnings Details
11/13/2012Q312$0.08($0.01)$19.70 million$16.90 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for Heska Corporation (NASDAQ:HSKA)
Current Year EPS Consensus Estimate: $1.35 EPS
Next Year EPS Consensus Estimate: $1.54 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q2 20162$0.13$0.16$0.15
Q3 20162$0.21$0.26$0.24
Q4 20162$0.38$0.39$0.39
Q1 20171$0.21$0.21$0.21
Q2 20171$0.34$0.34$0.34
Q3 20171$0.43$0.43$0.43
Q4 20171$0.42$0.42$0.42
Q1 20181$0.25$0.25$0.25
Q2 20181$0.38$0.38$0.38
Q3 20181$0.48$0.48$0.48
Q4 20181$0.49$0.49$0.49
(Data provided by Zacks Investment Research)

Dividends

Dividend History for Heska Corporation (NASDAQ:HSKA)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading History for Heska Corporation (NASDAQ:HSKA)
Insider Ownership Percentage: 15.30%
Institutional Ownership Percentage: 77.40%
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
1/10/2017Jason A. NapolitanoCOOSell5,000$74.73$373,650.00View SEC Filing  
11/29/2016G Irwin GordonDirectorSell3,000$66.11$198,330.00View SEC Filing  
11/28/2016John McmahonCFOSell1,999$65.64$131,214.36View SEC Filing  
11/22/2016Rod LippincottEVPSell5,000$64.85$324,250.00View SEC Filing  
9/1/2016Jason A. NapolitanoCFOSell5,000$52.53$262,650.00View SEC Filing  
8/29/2016Kevin S WilsonCEOSell20,000$51.80$1,036,000.00View SEC Filing  
8/24/2016John McmahonVPSell137$51.30$7,028.10View SEC Filing  
8/9/2016Steve AsakowiczEVPSell4,698$52.55$246,879.90View SEC Filing  
8/3/2016Kevin S WilsonCEOSell30,736$47.34$1,455,042.24View SEC Filing  
7/29/2016Kevin S WilsonCEOSell20$43.95$879.00View SEC Filing  
7/20/2016Kevin S WilsonCEOSell3,779$44.02$166,351.58View SEC Filing  
7/18/2016Kevin S WilsonCEOSell5,465$44.31$242,154.15View SEC Filing  
7/8/2016Kevin S WilsonCEOSell10,000$42.37$423,700.00View SEC Filing  
7/7/2016Jason A. NapolitanoCFOSell20,000$41.00$820,000.00View SEC Filing  
7/6/2016Kevin S WilsonCEOSell5,960$40.27$240,009.20View SEC Filing  
7/1/2016Kevin S WilsonCEOSell14,040$38.94$546,717.60View SEC Filing  
6/2/2016Kevin S WilsonCEOSell20,000$36.74$734,800.00View SEC Filing  
5/12/2016Kevin S WilsonCEOSell5,000$38.50$192,500.00View SEC Filing  
5/10/2016Kevin S WilsonCEOSell15,000$36.75$551,250.00View SEC Filing  
5/10/2016Michael J McginleyInsiderSell5,998$36.50$218,927.00View SEC Filing  
5/10/2016Sharon L RileyDirectorSell5,000$36.87$184,350.00View SEC Filing  
5/9/2016Kevin S WilsonCEOSell11,000$35.61$391,710.00View SEC Filing  
5/5/2016Sharon L RileyDirectorSell15,000$35.66$534,900.00View SEC Filing  
5/3/2016Jason A NapolitanoCFOSell5,000$35.75$178,750.00View SEC Filing  
3/8/2016Sharon L RileyDirectorBuy1,000$32.49$32,490.00View SEC Filing  
1/27/2016Jason A NapolitanoCFOSell15,000$37.00$555,000.00View SEC Filing  
12/29/2015Jason A. NapolitanoCFOSell3,700$40.03$148,111.00View SEC Filing  
12/3/2015Kevin S WilsonCEOSell6,000$35.50$213,000.00View SEC Filing  
11/25/2015Michael J. McginleyinsiderSell958$33.62$32,207.96View SEC Filing  
11/24/2015Michael J. McginleyinsiderSell1,427$33.33$47,561.91View SEC Filing  
9/11/2015Jason A NapolitanoCFOSell1,699$33.51$56,933.49View SEC Filing  
8/31/2015Jason A. NapolitanoCFOSell4,998$33.59$167,882.82View SEC Filing  
8/31/2015Robert B. GrieveinsiderSell11,098$33.77$374,779.46View SEC Filing  
8/27/2015Robert B. GrieveinsiderSell3,604$33.79$121,779.16View SEC Filing  
8/17/2015Kevin S WilsonCEOSell2,498$34.90$87,180.20View SEC Filing  
8/17/2015Robert B GrieveInsiderSell8,033$34.91$280,432.03View SEC Filing  
8/14/2015Kevin S WilsonCEOSell2,101$34.90$73,324.90View SEC Filing  
8/14/2015Rod LippincottEVPSell3,898$34.19$133,272.62View SEC Filing  
7/13/2015Robert B GrieveInsiderSell1,000$29.99$29,990.00View SEC Filing  
6/8/2015Kevin S WilsonCEOSell11,810$30.08$355,244.80View SEC Filing  
6/3/2015Robert B GrieveInsiderSell17,000$31.36$533,120.00View SEC Filing  
6/1/2015Jason A NapolitanoCFOSell7,536$32.26$243,111.36View SEC Filing  
5/22/2015Steven M EylEVPSell5,981$30.19$180,566.39View SEC Filing  
4/24/2015Robert B GrieveInsiderSell6,000$29.67$178,020.00View SEC Filing  
4/13/2015Robert B GrieveInsiderSell4,000$26.54$106,160.00View SEC Filing  
3/9/2015Jason A NapolitanoCFOSell5,765$26.02$150,005.30View SEC Filing  
3/9/2015Kevin S WilsonCEOSell10,000$25.38$253,800.00View SEC Filing  
3/9/2015Robert B GrieveInsiderSell2,000$25.26$50,520.00View SEC Filing  
11/30/2014David E SveenDirectorBuy21,428$14.00$299,992.00View SEC Filing  
11/30/2014Kevin S WilsonCEOSell28,928$14.00$404,992.00View SEC Filing  
11/21/2014Robert B GrieveInsiderSell6,500$15.25$99,125.00View SEC Filing  
11/3/2014William A AylesworthDirectorSell5,000$13.67$68,350.00View SEC Filing  
8/4/2014Robert B GrieveDirectorSell12,000$13.57$162,840.00View SEC Filing  
5/14/2014William AylesworthDirectorSell4,200$10.89$45,738.00View SEC Filing  
3/31/2014Carol WrennDirectorBuy1,000$10.50$10,500.00View SEC Filing  
3/31/2014Robert GrieveCEOSell7,000$10.50$73,500.00View SEC Filing  
3/1/2013William A AylesworthDirectorBuy2,000$8.34$16,680.00View SEC Filing  
10/3/2012Master Fund L.P. CmcMajor ShareholderSell11,002$9.54$104,959.08View SEC Filing  
8/28/2012William A AylesworthDirectorBuy2,000$7.95$15,900.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Latest Headlines for Heska Corporation (NASDAQ:HSKA)
DateHeadline
News IconNew Analyst Ratings On Heska Corporation (HSKA) - NewsDen (NASDAQ:HSKA)
newsden.net - February 25 at 12:12 AM
News IconStock Watch for Heska Corporation (NASDAQ:HSKA) - Midway Monitor (NASDAQ:HSKA)
midwaymonitor.com - February 25 at 12:12 AM
News IconWhat are Analysts Expecting for Heska Corporation (NASDAQ:HSKA) Earnings? - Aiken Advocate (NASDAQ:HSKA)
aikenadvocate.com - February 18 at 7:07 AM
News IconEquity in Focus: Heska Corporation (NASDAQ:HSKA) - Rives Journal (NASDAQ:HSKA)
rivesjournal.com - February 15 at 12:05 AM
finance.yahoo.com logoHeska Schedules Fourth Quarter and Year-End 2016 Financial Results Conference Call for February 28, 2017 (NASDAQ:HSKA)
finance.yahoo.com - January 31 at 6:28 PM
News IconUpward Mounting Stock Reaches New Heights: Heska Corporation (NASDAQ:HSKA) - Wall Street Beacon (NASDAQ:HSKA)
wsbeacon.com - January 30 at 11:33 PM
News IconWhat are Research Firms Saying About Heska Corporation (NASDAQ:HSKA)? - Aiken Advocate (NASDAQ:HSKA)
aikenadvocate.com - January 27 at 7:41 PM
News IconLevels in View on Shares of Heska Corporation (NASDAQ:HSKA ... - The Tribune (NASDAQ:HSKA)
lakecitytribune.com - January 26 at 1:18 AM
News IconTrading Watch: ADX and CCI Review for Heska Corporation (HSKA) - Springdale Times (NASDAQ:HSKA)
springdaletimes.com - January 25 at 3:15 PM
News IconStock Touches New High Post-Inauguration: Heska Corporation (NASDAQ:HSKA) - Wall Street Beacon (NASDAQ:HSKA)
wsbeacon.com - January 23 at 11:02 PM
realistinvestor.com logoHeska Corporation (NASDAQ:HSKA) Mean Rating At $2.14 - RealistInvestor.com (NASDAQ:HSKA)
www.realistinvestor.com - January 17 at 6:19 PM
News IconWill The Needle Move For Heska Corporation (NASDAQ:HSKA) Shares This Earnings Season? - Wall Street Beacon (NASDAQ:HSKA)
wsbeacon.com - January 17 at 6:19 PM
seekingalpha.com logoWho Could Be The Next Buyout Target In Animal Health? (NASDAQ:HSKA)
seekingalpha.com - January 15 at 5:25 PM
News IconMarkets End Mostly Higher, How Did This Stock Fare: Heska Corporation (NASDAQ:HSKA) - Wall Street Beacon (NASDAQ:HSKA)
wsbeacon.com - January 14 at 10:48 PM
News IconStock Vaulting to Uncharted Territory: Heska Corporation (NASDAQ:HSKA) - Wall Street Beacon (NASDAQ:HSKA)
wsbeacon.com - January 12 at 11:14 PM
investornewswire.com logoSentiments And Ratings Alert: Heska Corporation (NASDAQ:HSKA) - Investor Newswire (NASDAQ:HSKA)
www.investornewswire.com - January 6 at 6:24 PM
realistinvestor.com logoHeska Corporation (NASDAQ:HSKA) Quarterly EPS At $0.45 - RealistInvestor.com (NASDAQ:HSKA)
www.realistinvestor.com - January 2 at 5:45 PM
marketexclusive.com logoHESKA CORPORATION (NASDAQ:HSKA) Files An 8-K Departure of Directors or Certain Officers; Election of Directors ... - Market Exclusive (NASDAQ:HSKA)
marketexclusive.com - January 1 at 5:37 PM
4-traders.com logoPutnam Announces Dividend Rates for Open-End Funds (NASDAQ:HSKA)
www.4-traders.com - December 30 at 6:10 PM
zacks.com logoAmphastar Stock Down on CRL for Asthma Drug in the U.S. (NASDAQ:HSKA)
www.zacks.com - December 28 at 11:01 AM
finance.yahoo.com logoApricus Launches Vitaros in Lebanon for Erectile Dysfunction (NASDAQ:HSKA)
finance.yahoo.com - December 28 at 11:01 AM
finance.yahoo.com logoShire Gets FDA Approval for Label Expansion of Adynovate (NASDAQ:HSKA)
finance.yahoo.com - December 28 at 11:01 AM
finance.yahoo.com logoIonis Receives $5 Million Milestone from J&J Unit for GI Drug (NASDAQ:HSKA)
finance.yahoo.com - December 23 at 5:59 PM
us.rd.yahoo.com logoIncyte/Merus Ink Collaboration for Bispecific Antibodies (NASDAQ:HSKA)
us.rd.yahoo.com - December 22 at 6:01 PM
News IconCompany Levels in Review: Heska Corporation (NASDAQ:HSKA) - OIB News (NASDAQ:HSKA)
oibnews.com - December 21 at 11:39 PM
zacks.com logoRoche (RHHBY) MS Drug FDA Review Date Extended in U.S. (NASDAQ:HSKA)
www.zacks.com - December 21 at 6:38 PM
zacks.com logoJuno Gets Breakthrough Therapy Status for Lymphoma Drug (NASDAQ:HSKA)
www.zacks.com - December 21 at 10:15 AM
finance.yahoo.com logoBiogen (BIIB) Board Okays Hemophilia Business Spin-off (NASDAQ:HSKA)
finance.yahoo.com - December 21 at 10:15 AM
finance.yahoo.com logoJ&J Files for FDA Approval of Simponi Aria Label Expansion (NASDAQ:HSKA)
finance.yahoo.com - December 21 at 10:15 AM
News IconFollowing the Numbers for Heska Corporation (NASDAQ:HSKA) - Liberty News (NASDAQ:HSKA)
libertynewsrecord.com - December 20 at 11:01 PM
finance.yahoo.com logoAmgen Files for Approval of Osteoporosis Drug in Japan (NASDAQ:HSKA)
finance.yahoo.com - December 20 at 11:07 AM
News IconFollowing FCF Scores for Heska Corporation (NASDAQ:HSKA) - Marion Business Daily (NASDAQ:HSKA)
marionbusinessdaily.com - December 19 at 11:45 AM
News IconLooking at the Levels for Heska Corporation (NASDAQ:HSKA) - Liberty News (NASDAQ:HSKA)
libertynewsrecord.com - December 19 at 11:45 AM
News IconUpdate on Valuation Formula's For Heska Corporation (NASDAQ:HSKA) - Marion Business Daily (NASDAQ:HSKA)
marionbusinessdaily.com - December 15 at 6:20 AM
News IconInvestor Watch: Narrowing in on Heska Corporation (NASDAQ:HSKA) - Liberty News (NASDAQ:HSKA)
libertynewsrecord.com - December 15 at 6:20 AM
News IconROIC Watch for Heska Corporation (NASDAQ:HSKA) - Liberty News (NASDAQ:HSKA)
libertynewsrecord.com - December 12 at 10:55 PM
insidermonkey.com logoIs Heska Corp (HSKA) A Good Stock To Buy? (NASDAQ:HSKA)
www.insidermonkey.com - December 10 at 5:25 PM
News IconInvestor Monitor: Narrowing in on Heska Corporation (NASDAQ:HSKA) - The Business Journal (NASDAQ:HSKA)
belmontbusinessjournal.com - December 6 at 3:32 PM
News IconInvestor Corner: Checking the Numbers for Heska Corporation (NASDAQ:HSKA) - OIB News (NASDAQ:HSKA)
oibnews.com - December 6 at 3:32 PM
realistinvestor.com logoMean Rating Of Heska Corporation (NASDAQ:HSKA) At $2.14 - RealistInvestor.com (NASDAQ:HSKA)
www.realistinvestor.com - December 5 at 11:01 AM
News IconMF Rank Review for Heska Corporation (NASDAQ:HSKA) - Liberty News (NASDAQ:HSKA)
libertynewsrecord.com - December 1 at 10:49 PM
finance.yahoo.com logoTime to Focus on Heska (HSKA) for Strong Earnings Growth Potential (NASDAQ:HSKA)
finance.yahoo.com - November 30 at 5:54 PM
finance.yahoo.com logoValeant (VRX) Ups Sales Force to Support Xifaxan/Relistor (NASDAQ:HSKA)
finance.yahoo.com - November 30 at 9:26 AM
us.rd.yahoo.com logoGlaxo (GSK) Files Regulatory Application for Shingrix in EU (NASDAQ:HSKA)
us.rd.yahoo.com - November 29 at 4:45 PM
us.rd.yahoo.com logoGlaxo (GSK) Files Regulatory Application for Shingrix in EU (NASDAQ:HSKA)
us.rd.yahoo.com - November 29 at 4:45 PM
finance.yahoo.com logoCoverage initiated on Heska Corp by The Benchmark Company (NASDAQ:HSKA)
finance.yahoo.com - November 29 at 4:45 PM
finance.yahoo.com logoCoverage initiated on Heska Corp by The Benchmark Company (NASDAQ:HSKA)
finance.yahoo.com - November 29 at 4:45 PM
finance.yahoo.com logoOPKO Health (OPK) Launches Kidney Drug Rayaldee in U.S. (NASDAQ:HSKA)
finance.yahoo.com - November 25 at 10:43 AM
finance.yahoo.com logoMerck's New Drugs, Cost Management to Fuel Growth in 2017 (NASDAQ:HSKA)
finance.yahoo.com - November 25 at 10:43 AM
finance.yahoo.com logoJuno's ROCKET Study on Clinical Hold Again, Shares Down (NASDAQ:HSKA)
finance.yahoo.com - November 24 at 8:32 AM

Social

What is Heska Corporation's stock symbol?

Heska Corporation trades on the NASDAQ under the ticker symbol "HSKA."

Where is Heska Corporation's stock going? Where will Heska Corporation's stock price be in 2017?

5 equities research analysts have issued 12 month target prices for Heska Corporation's stock. Their predictions range from $70.50 to $100.00. On average, they anticipate Heska Corporation's share price to reach $80.50 in the next year.

When will Heska Corporation announce their earnings?

Heska Corporation is scheduled to release their next quarterly earnings announcement on Wednesday, March, 1st 2017.

Who owns Heska Corporation stock?

Heska Corporation's stock is owned by many different of institutional and retail investors. Top institutional investors include Russell Investments Group Ltd. (2.49%), State Street Corp (2.24%), Thrivent Financial for Lutherans (2.21%), Cortina Asset Management LLC (1.88%), Bogle Investment Management L P DE (0.86%) and Oberweis Asset Management Inc. (0.85%). Company insiders that own Heska Corporation stock include G Irwin Gordon, Jason A Napolitano, John Mcmahon, Kevin S Wilson, Michael J Mcginley, Robert B Grieve, Rod Lippincott, Sharon L Riley, Steve Asakowicz and Steven M Eyl.

Who sold Heska Corporation stock? Who is selling Heska Corporation stock?

Heska Corporation's stock was sold by a variety of institutional investors in the last quarter, including Cortina Asset Management LLC, Oxford Asset Management, GSA Capital Partners LLP, Fred Alger Management Inc., Ranger Investment Management L.P., Menta Capital LLC, Gamco Investors INC. ET AL and AQR Capital Management LLC. Company insiders that have sold Heska Corporation stock in the last year include G Irwin Gordon, Jason A Napolitano, John Mcmahon, Kevin S Wilson, Michael J Mcginley, Rod Lippincott, Sharon L Riley and Steve Asakowicz.

Who bought Heska Corporation stock? Who is buying Heska Corporation stock?

Heska Corporation's stock was acquired by a variety of institutional investors in the last quarter, including Russell Investments Group Ltd., State Street Corp, Oberweis Asset Management Inc., Royce & Associates LP, Elkfork Partners LLC, Allianz Asset Management AG, Two Sigma Investments LP and Cadence Capital Management LLC.

How do I buy Heska Corporation stock?

Shares of Heska Corporation can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of Heska Corporation stock cost?

One share of Heska Corporation stock can currently be purchased for approximately $81.38.

Heska Corporation (NASDAQ:HSKA) Chart for Monday, February, 27, 2017


Institutional Ownership Chart

Institutional Ownership by Quarter for Heska Corporation (NASDAQ:HSKA)

Earnings History Chart

Earnings by Quarter for Heska Corporation (NASDAQ:HSKA)

Dividend History Chart

Dividend Payments by Quarter for Heska Corporation (NASDAQ:HSKA)

Last Updated on 2/27/2017 by MarketBeat.com Staff